Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression

Seminars in Oncology

Volumn 43, Issue 1, 2016, Pages 154-160

  Gucalp, Ayca ^a,b   Iyengar, Neil M ^a,b   Hudis, Clifford A ^a,b   Dannenberg, Andrew J ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adipose tissue; Body mass index; Cancer prevention; Inflammation; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANDROGEN; ESTROGEN; LEPTIN;

ADIPOSE TISSUE; ADIPOSE TISSUE DYSFUNCTION; CANCER GROWTH; CANCER PREVENTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STEROIDOGENESIS; BIOSYNTHESIS; COMPLICATION; METABOLISM; NEOPLASMS; PATHOPHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANDROGENS; ESTROGENS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; NEOPLASMS; OBESITY;

EID: 84960327783     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2015.09.012     Document Type: Review

References (125)

1. World Health Organization. Obesity and overweight fact sheet. http://www.who.int/mediacentre/factsheets/fs311/en/index.html, March 2011
2. J. Levi, L.M. Segal, R. St. Laurent, and et al. F as in fat: how obesity threatens America's future 2012 Trust for America's Health 2012
3. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591
4. R.C. van Kruijsdijk, E. van der Wall, and F.L. Visseren Obesity and cancer: the role of dysfunctional adipose tissue Cancer Epidemiol Biomarkers Prev 18 2009 2569 2578
5. A.P. Polednak Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers Cancer Detect Prev 32 2008 190 199
6. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
7. N.M. Iyengar, C.A. Hudis, and A.J. Dannenberg Obesity and inflammation Am Soc Clin Oncol Educ Book 2013 46 51
8. H.H. Yoon, M.A. Lewis, Q. Shi, and et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma J Clin Oncol 29 2011 4561 4567
9. M.W. Rajala, and P.E. Scherer Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis Endocrinology 144 2003 3765 3773
10. A. Guilherme, J.V. Virbasius, V. Puri, and et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes Nat Rev Mol Cell Biol 9 2008 367 377
11. S.D. Hursting, J. Digiovanni, A.J. Dannenberg, and et al. Obesity, energy balance, and cancer: new opportunities for prevention Cancer Prev Res (Phila) 5 2012 1260 1272
12. O.T. Hardy, R.A. Perugini, S.M. Nicoloro, and et al. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity Surg Obes Relat Dis 7 2011 60 67
13. M. Deepa, M. Papita, A. Nazir, and et al. Lean people with dysglycemia have a worse metabolic profile than centrally obese people without dysglycemia Diabetes Technol Ther 16 2014 91 96
14. X.J. Xu, M.S. Gauthier, D.T. Hess, and et al. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue J Lipid Res. 53 2012 792 801
15. Kloting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2101;299:E506-15.
16. G.V. Denis, and M.S. Obin 'Metabolically healthy obesity': origins and implications Mol Aspects Med 34 2013 59 70
17. P. Arner Catecholamine-induced lipolysis in obesity Int J Obesity 23 1999 10 13
18. J. Vague The degree of masculine differentiation of obesities - a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease Am J Clin Nutr 4 1956 20 34
19. M.J. Khandekar, P. Cohen, and B.M. Spiegelman Molecular mechanisms of cancer development in obesity Nat Rev Cancer 11 2011 886 895
20. M.N. Pollak, E.S. Schernhammer, and S.E. Hankinson Insulin-like growth factors and neoplasia Nat Rev Cancer 4 2004 505 518
21. P.J. Goodwin, M. Ennis, K.I. Pritchard, and et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study J Clin Oncol 20 2002 42 51
22. J. Ma, H. Li, E. Giovannucci, and et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis Lancet Oncol 9 2008 1039 1047
23. B.B. Barone, H.C. Yeh, C.F. Snyder, and et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis JAMA 300 2008 2754 2764
24. K.K. Wong, J.A. Engelman, and L.C. Cantley Targeting the PI3K signaling pathway in cancer Curr Opin Genet Dev 20 2010 87 90
25. R. Zoncu, A. Efeyan, and D.M. Sabatini mTOR: from growth signal integration to cancer, diabetes and ageing Nat Rev Mol Cell Biol 12 2011 21 35
26. E.D. Rosen, and B.M. Spiegelman What we talk about when we talk about fat Cell 156 2014 20 44
27. N.M. Iyengar, P.G. Morris, C.A. Hudis, and et al. Obesity, inflammation, and breast cancer A.J. Dannenberg, N.A. Berger, Obesity, inflammation, and cancer. Energy balance and cancer 2013 Springer New York, NY 181 217
28. K.G. Hofbauer Molecular pathways to obesity Int J Obes Relat Metab Disord 26 Suppl 2 2002 S18 S27
29. K.G. Alberti, R.H. Eckel, S.M. Grundy, and et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
30. P. Pothiwala, S.K. Jain, and S. Yaturu Metabolic syndrome and cancer Metab Syndr Relat Disord 7 2009 279 288
31. I. Capasso, E. Esposito, F. Pentimalli, and et al. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience Cancer Biol Ther 10 2010 1240 1243
32. L.A. Porto, K.J. Lora, J.C. Soares, and et al. Metabolic syndrome is an independent risk factor for breast cancer Arch Gynecol Obstet 284 2011 1271 1276
33. V. Rosato, C. Bosetti, R. Talamini, and et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women Ann Oncol 22 2011 2687 2692
34. H. Tilg, and A.R. Moschen Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 2006 772 783
35. D. Housa, J. Housova, Z. Vernerova, and et al. Adipocytokines and cancer Physiol Res 55 2006 233 244
36. J.D. Bub, T. Miyazaki, and Y. Iwamoto Adiponectin as a growth inhibitor in prostate cancer cells Biochem Biophys Res Commun 340 2006 1158 1166
37. A.Y. Kim, Y.S. Lee, K.H. Kim, and et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation Mol Endocrinol 24 2010 1441 1452
38. L. Cong, J. Gasser, J. Zhao, and et al. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2 Endocr Relat Cancer 14 2007 713 720
39. M.E. Grossmann, K.J. Nkhata, N.K. Mizuno, and et al. Effects of adiponectin on breast cancer cell growth and signaling Br J Cancer 98 2008 370 379
40. Y. Kamada, H. Matsumoto, S. Tamura, and et al. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model J Hepatol 47 2007 556 564
41. T. Fujisawa, H. Endo, A. Tomimoto, and et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition Gut 57 2008 1531 1538
42. Y. Miyoshi, T. Funahashi, S. Kihara, and et al. Association of serum adiponectin levels with breast cancer risk Clin Cancer Res 9 2003 5699 5704
43. P.T. Soliman, D. Wu, G. Tortolero-Luna, and et al. Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 2006 2376 2381
44. X.T. Xu, Q. Xu, J.L. Tong, and et al. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma J Dig Dis 12 2011 234 244
45. K. Michalakis, C.J. Williams, N. Mitsiades, and et al. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study Cancer Epidemiol Biomarkers Prev 16 2007 308 313
46. H. Li, M.J. Stampfer, L. Mucci, and et al. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival Clin Chem 56 2010 34 43
47. V.G. Kaklamani, K.B. Wisinski, M. Sadim, and et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk JAMA 300 2008 1523 1531
48. V.G. Kaklamani, M. Sadim, A. Hsi, and et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk Cancer Res 68 2008 3178 3184
49. V. Kaklamani, N. Yi, K. Zhang, and et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk Metabolism 60 2011 1234 1243
50. T. Jarde, S. Perrier, M.P. Vasson, and et al. Molecular mechanisms of leptin and adiponectin in breast cancer Eur J Cancer 47 2011 33 43
51. S. Fogarty, and D.G. Hardie Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim Biophys Acta 1804 2010 581 591
52. T. Jarde, F. Caldefie-Chezet, M. Damez, and et al. Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma Oncol Rep 19 2008 905 911
53. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
54. D. Sharma, N.K. Saxena, P.M. Vertino, and et al. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways Endocr Relat Cancer 13 2006 629 640
55. J.H. Choi, S.H. Park, P.C. Leung, and et al. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells J Clin Endocrinol Metab 90 2005 207 210
56. M.R. Hoda, S.J. Keely, L.S. Bertelsen, and et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells Br J Surg 94 2007 346 354
57. M. Onuma, J.D. Bub, T.L. Rummel, and et al. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase J Biol Chem 278 2003 42660 42667
58. V.M. Chia, P.A. Newcomb, J.W. Lampe, and et al. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk Cancer Epidemiol Biomarkers Prev 16 2007 2697 2703
59. S. Uddin, R. Bu, M. Ahmed, and et al. Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer Mol Cancer 2009 8
60. M. Ishikawa, J. Kitayama, and H. Nagawa Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer Clin Cancer Res 10 2004 4325 4331
61. M.E. Grossmann, N.K. Mizuno, M.J. Bonorden, and et al. Role of the adiponectin leptin ratio in prostate cancer Oncol Res 18 2009 269 277
62. D. Sharma, J. Wang, P.P. Fu, and et al. Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis Hepatology 52 2010 1713 1722
63. N. Ashizawa, T. Yahata, J.H. Quan, and et al. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects Gynecol Oncol 119 2010 65 69
64. M.E. Grossmann, A. Ray, K.J. Nkhata, and et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes Cancer Metast Rev 29 2010 641 653
65. T. Mistry, J.E. Digby, K.M. Desai, and et al. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression BJU Int 101 2008 1317 1322
66. J. Chen, B. Tan, E. Karteris, and et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines Diabetologia 49 2006 1292 1302
67. M.P. Cleary, and M.E. Grossmann Minireview: Obesity and breast cancer: the estrogen connection Endocrinology 150 2009 2537 2542
68. G.K. Reeves, K. Pirie, V. Beral, and et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study BMJ 335 2007 1134
69. C.I. Li, J.R. Daling, and K.E. Malone Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998 J Clin Oncol 21 2003 28 34
70. T.J. Key, P.N. Appleby, G.K. Reeves, and et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J Natl Cancer Inst 95 2003 1218 1226
71. A.M. Lorincz, and S. Sukumar Molecular links between obesity and breast cancer Endocr Relat Cancer 13 2006 279 292
72. E. Giovannucci, E.B. Rimm, Y. Liu, and et al. Body mass index and risk of prostate cancer in U.S. health professionals J Natl Cancer Inst 95 2003 1240 1244
73. J. Jayachandran, L.L. Banez, W.J. Aronson, and et al. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database Cancer 115 2009 5263 5271
74. A.S. Parker, D.D. Thiel, E. Bergstralh, and et al. Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies Prostate Cancer Prostatic Dis 16 2013 352 356
75. P.E. Lonergan, and D.J. Tindall Androgen receptor signaling in prostate cancer development and progression J Carcinog 10 2011 20
76. S. Dhindsa, M.G. Miller, C.L. McWhirter, and et al. Testosterone concentrations in diabetic and nondiabetic obese men Diabetes Care 33 2010 1186 1192
77. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 2010 219 246
78. B.L. Pierce, R. Ballard-Barbash, L. Bernstein, and et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients J Clin Oncol 27 2009 3437 3444
79. A. Mantovani, P. Allavena, A. Sica, and et al. Cancer-related inflammation Nature 454 2008 436 444
80. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
81. O. Osborn, and J.M. Olefsky The cellular and signaling networks linking the immune system and metabolism in disease Nat Med 18 2012 363 374
82. R. Monteiro, and I. Azevedo Chronic inflammation in obesity and the metabolic syndrome Mediators Inflamm 2010
83. K. Subbaramaiah, L.R. Howe, P. Bhardwaj, and et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland Cancer Prev Res (Phila) 4 2011 329 346
84. P.G. Morris, C.A. Hudis, D. Giri, and et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer Cancer Prev Res (Phila) 4 2011 1021 1029
85. T. Bachelot, I. Ray-Coquard, C. Menetrier-Caux, and et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients Br J Cancer 88 2003 1721 1726
86. P. Dandona, R. Weinstock, K. Thusu, and et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss J Clin Endocrinol Metab 83 1998 2907 2910
87. B. Vozarova, C. Weyer, K. Hanson, and et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion Obes Res 9 2001 414 417
88. X. Sun, P. Casbas-Hernandez, C. Bigelow, and et al. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression Breast Cancer Res Treat 131 2012 1003 1012
89. K. Subbaramaiah, P.G. Morris, X.K. Zhou, and et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women Cancer Discov 2 2012 356 365
90. Y. Zhao, V.R. Agarwal, C.R. Mendelson, and et al. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 1996 5739 5742
91. N. Irahara, Y. Miyoshi, T. Taguchi, and et al. Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer Int J Cancer 118 2006 1915 1921
92. N.M. Iyengar, P.G. Morris, X.K. Zhou, and et al. Menopause is a determinant of breast adipose inflammation Cancer Prev Res (Phila) 8 2015 349 358
93. C.A. Hudis, K. Subbaramaiah, P.G. Morris, and et al. Breast cancer risk reduction: no pain, no gain? J Clin Oncol 30 2012 3436 3438
94. L.R. Howe, K. Subbaramaiah, C.A. Hudis, and et al. Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer Clin Cancer Res 19 2013 6074 6083
95. S. Cinti, G. Mitchell, G. Barbatelli, and et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J Lipid Res 46 2005 2347 2355
96. K. Clement, N. Viguerie, C. Poitou, and et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects FASEB J 18 2004 1657 1669
97. J.A. Ligibel, and P.J. Goodwin NEW and RENEW: building the case for weight loss in breast cancer J Clin Oncol 30 2012 2294 2296
98. W. Demark-Wahnefried, M.C. Morey, R. Sloane, and et al. Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors J Clin Oncol 30 2012 2354 2361
99. K.L. Campbell, K.E. Foster-Schubert, C.M. Alfano, and et al. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial J Clin Oncol 30 2012 2314 2326
100. R.T. Chlebowski, E. Aiello, and A. McTiernan Weight loss in breast cancer patient management J Clin Oncol 20 2002 1128 1143
101. M.D. Holmes, W.Y. Chen, D. Feskanich, and et al. Physical activity and survival after breast cancer diagnosis JAMA 293 2005 2479 2486
102. C.N. Holick, P.A. Newcomb, A. Trentham-Dietz, and et al. Physical activity and survival after diagnosis of invasive breast cancer Cancer Epidemiol Biomarkers Prev 17 2008 379 386
103. M.L. Irwin, A.W. Smith, A. McTiernan, and et al. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study J Clin Oncol 26 2008 3958 3964
104. X. Chen, W. Lu, W. Zheng, and et al. Exercise after diagnosis of breast cancer in association with survival Cancer Prev Res (Phila) 4 2011 1409 1418
105. R.T. Chlebowski, G.L. Blackburn, C.A. Thomson, and et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study J Natl Cancer Inst 98 2006 1767 1776
106. P. Bhardwaj, B. Du, X.K. Zhou, and et al. Caloric restriction reverses obesity-induced mammary gland inflammation in mice Cancer Prev Res (Phila) 6 2013 282 289
107. J.P. Bastard, C. Jardel, E. Bruckert, and et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss J Clin Endocrinol Metab 85 2000 3338 3342
108. K. Esposito, A. Pontillo, C. Di Palo, and et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial JAMA 289 2003 1799 1804
109. I. Imayama, C.M. Ulrich, C.M. Alfano, and et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial Cancer Res 72 2012 2314 2326
110. E.F. van Rossum, B.J. Nicklas, K.E. Dennis, and et al. Leptin responses to weight loss in postmenopausal women: relationship to sex-hormone binding globulin and visceral obesity Obes Res 8 2000 29 35
111. R. Cancello, C. Henegar, N. Viguerie, and et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery induced weight loss Diabetes 54 2005 2277 2286
112. T.D. Adams, A.M. Stroup, R.E. Gress, and et al. Cancer incidence and mortality after gastric bypass surgery Obesity 17 2009 796 802
113. L. Sjostrom Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery J Intern Med 273 2013 219 234
114. P.J. Goodwin, K.I. Pritchard, M. Ennis, and et al. Insulin-lowering effects of metformin in women with early breast cancer Clin Breast Cancer 8 2008 501 505
115. A.J. Dannenberg, N.K. Altorki, J.O. Boyle, and et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer Lancet Oncol 2 2001 544 551
116. M.J. Higgins, T.M. Prowell, A.L. Blackford, and et al. A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer Breast Cancer Res Treat 131 2012 915 924
117. Gucalp A, Morris PG, Zhou XK, et al. A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease. ASCO Meeting Abstracts. 2014;32:TPS1615.
118. L. Kaizer, N.F. Boyd, V. Kriukov, and et al. Fish consumption and breast cancer risk: an ecological study Nutr Cancer 12 1989 61 68
119. M. Gago-Dominguez, J.M. Yuan, C.L. Sun, and et al. Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study Br J Cancer 89 2003 1686 1692
120. K. Hirose, T. Takezaki, N. Hamajima, and et al. Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women Int J Cancer 107 2003 276 282
121. T.M. Brasky, J.W. Lampe, J.D. Potter, and et al. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort Cancer Epidemiol Biomarkers Prev 19 2010 1696 1708
122. D.P. Rose, and J.M. Connolly Omega-3 fatty acids as cancer chemopreventive agents Pharmacol Ther 83 1999 217 244
123. L.D. Yee, D.C. Young, T.J. Rosol, and et al. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone J Nutr 135 2005 983 988
124. Docosahexaenoic acid in preventing recurrence in breast cancer survivors. https://clinicaltrials.gov/ct2/show/NCT01849250?term=DHA+breast+cancer&rank=6, March 2015.
125. N.M. Iyengar, C.A. Hudis, and A.J. Dannenberg Obesity and cancer: local and systemic mechanisms Ann Rev Med 66 2015 297 309